Your browser doesn't support javascript.
loading
Real-World Effectiveness of the mRNA COVID-19 Vaccines in Japan: A Case-Control Study.
Hara, Megumi; Furue, Takeki; Fukuoka, Mami; Iwanaga, Kentaro; Matsuishi, Eijo; Miike, Toru; Sakamoto, Yuichiro; Mukai, Naoko; Kinugasa, Yuki; Shigyo, Mutsumi; Sonoda, Noriko; Tanaka, Masato; Arase, Yasuko; Tanaka, Yosuke; Nakashima, Hitoshi; Irie, Shin; Hirota, Yoshio.
Afiliación
  • Hara M; Department of Preventive Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
  • Furue T; Fukuoka City Office, 1-8-1 Tenjin, Chuohku, Fukuoka 810-8620, Japan.
  • Fukuoka M; Saga-Ken Medical Centre Koseikan, 400 Kase-Town, Saga 840-8571, Japan.
  • Iwanaga K; Saga-Ken Medical Centre Koseikan, 400 Kase-Town, Saga 840-8571, Japan.
  • Matsuishi E; Saga-Ken Medical Centre Koseikan, 400 Kase-Town, Saga 840-8571, Japan.
  • Miike T; Department of Emergency Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga 849-8501, Japan.
  • Sakamoto Y; Department of Emergency Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga 849-8501, Japan.
  • Mukai N; Fukuoka City Jonan Ward Public Health Center, 6-1-1 Torikai, Jonan Ward, Fukuoka 814-0192, Japan.
  • Kinugasa Y; Fukuoka City Higashi Ward Public Health Center, 2-54-1 Hakozaki, Higashi Ward, Fukuoka 812-8653, Japan.
  • Shigyo M; Fukuoka City Hakata Ward Public Health Center, 2-9-3 Hakataeki-Mae, Hakata Ward, Fukuoka 812-8512, Japan.
  • Sonoda N; Fukuoka City Sawara Ward Public Health Center, 2-1-1 Momochi, Sawara Ward, Fukuoka 814-8501, Japan.
  • Tanaka M; Fukuoka City Office, 1-8-1 Tenjin, Chuohku, Fukuoka 810-8620, Japan.
  • Arase Y; Fukuoka City Office, 1-8-1 Tenjin, Chuohku, Fukuoka 810-8620, Japan.
  • Tanaka Y; Kanenokuma Hospital, SOUSEIKAI Medical Group (Medical Co. LTA), Hakata-Ku, Fukuoka 812-0863, Japan.
  • Nakashima H; SOUSEIKAI Medical Group (Medical Co. LTA), Hakata-Ku, Fukuoka 812-0025, Japan.
  • Irie S; SOUSEIKAI Medical Group (Medical Co. LTA), Hakata-Ku, Fukuoka 812-0025, Japan.
  • Hirota Y; Clinical Epidemiology Research Center, SOUSEIKAI Medical Group (Medical Co. LTA), Higashi-Ku, Fukuoka 813-0017, Japan.
Vaccines (Basel) ; 10(5)2022 May 14.
Article en En | MEDLINE | ID: mdl-35632535
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article